메뉴 건너뛰기




Volumn 17, Issue 6, 2011, Pages 208-213

A study of patients with Clostridium difficile infection hospitalized at Brno Clinic of Infectious Diseases in 2007-2010;Analýza souboru pacientů s onemocněním vyvolaným toxinem Clostridium difficile hospitalizovaných na Klinice infekčních chorob v Brně v letech 2007-2010

Author keywords

Antibiotic associated diarrhoea; Clostridium difficile infection; Treatment

Indexed keywords

ANTIBIOTIC AGENT; PROTON PUMP INHIBITOR;

EID: 84856042542     PISSN: 1211264X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (6)

References (25)
  • 1
    • 79551705514 scopus 로고    scopus 로고
    • Výskyt a charakter infekcí vyvolaných Clostridium difficile u pacientů s průjmovým onemocněním v pražské fakultní nemocnici
    • Polívková S, Sýkorová B, Dž upová O, Reisingerová M, Beneš J. Výskyt a charakter infekcí vyvolaných Clostridium difficile u pacientů s průjmovým onemocněním v pražské fakultní nemocnici. Klin mikrobiol inf lék. 2010;16(6):206-210.
    • (2010) Klin Mikrobiol Inf Lék , vol.16 , Issue.6 , pp. 206-210
    • Polívková, S.1    Sýkorová, B.2    Dž upová, O.3    Reisingerová, M.4    Beneš, J.5
  • 3
    • 70649111291 scopus 로고    scopus 로고
    • Distribution of Clostridium difficile strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005-2007
    • Cheknis AK, Sambol SP, Davidson DM, et al. Distribution of Clostridium difficile strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005-2007. Anaerobe. 2009; 15: 230-233.
    • (2009) Anaerobe , vol.15 , pp. 230-233
    • Cheknis, A.K.1    Sambol, S.P.2    Davidson, D.M.3
  • 4
    • 79952640156 scopus 로고    scopus 로고
    • Geographical clustering of cases of infection with moxifloxacin-resistant Clostridium difficile PCR- ribotypes 012, 017 and 046 in Sweden, 2008 and 2009
    • pii =19 813
    • Akerlund T, Alefjord I, Dohnhammar U, et al. Geographical clustering of cases of infection with moxifloxacin-resistant Clostridium difficile PCR- ribotypes 012, 017 and 046 in Sweden, 2008 and 2009. Euro Surveill. 2011;16(10): pii =19 813.
    • (2011) Euro Surveill , vol.16 , Issue.10
    • Akerlund, T.1    Alefjord, I.2    Dohnhammar, U.3
  • 5
    • 78650825355 scopus 로고    scopus 로고
    • Clostridium difficile infection in Europe: A hospital-based survey
    • Bauer MP, Notermans DW, van Benthem BH, et al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet 2011; 377: 63-73.
    • (2011) Lancet , vol.377 , pp. 63-73
    • Bauer, M.P.1    Notermans, D.W.2    Van Benthem, B.H.3
  • 7
    • 34848889558 scopus 로고    scopus 로고
    • Clostridium difficile: Emergence of hypervirulence and fluoroquinolone resistance
    • DOI 10.1007/s15010-007-6113-0
    • Razavi B, Apisarnthanarak A, Mundy LM. Clostridium difficile: emergence of hypervirulence and fluoroquinolone resistance. Infection. 2007;35;5:300-307. (Pubitemid 47502344)
    • (2007) Infection , vol.35 , Issue.5 , pp. 300-307
    • Razavi, B.1    Apisarnthanarak, A.2    Mundy, L.M.3
  • 8
    • 77951026738 scopus 로고    scopus 로고
    • Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
    • Cohen SH, Gerding DN, Johnson S, et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431-455.
    • (2010) Infect Control Hosp Epidemiol , vol.31 , Issue.5 , pp. 431-455
    • Cohen, S.H.1    Gerding, D.N.2    Johnson, S.3
  • 9
    • 33947326884 scopus 로고    scopus 로고
    • Clostridium difficile-associated disease. Changing epidemiology and implications for management
    • Owens RC. Clostridium difficile-associated disease. Changing epidemiology and implications for management. Drugs. 2007;67(4):487-503.
    • (2007) Drugs , vol.67 , Issue.4 , pp. 487-503
    • Owens, R.C.1
  • 10
    • 33846156548 scopus 로고    scopus 로고
    • A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Québec
    • DOI 10.1086/510391
    • Hubert B, Loo VG, Bourgault AM, et al. A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Québec. CID. 2007;44:238-244. (Pubitemid 46079988)
    • (2007) Clinical Infectious Diseases , vol.44 , Issue.2 , pp. 238-244
    • Hubert, B.1    Loo, V.G.2    Bourgault, A.-M.3    Poirier, L.4    Dascal, A.5    Fortin, E.6    Dionne, M.7    Lorange, M.8
  • 11
    • 33846988271 scopus 로고    scopus 로고
    • Kolitida vyvolaná Clostridium difficile. Zpráva z kongresu ICAAC 2006
    • Beneš J, Sýkorová B. Kolitida vyvolaná Clostridium difficile. Zpráva z kongresu ICAAC 2006. Klin mikrobiol inf lék. 2006;12;6:247-251.
    • (2006) Klin Mikrobiol Inf Lék , vol.12 , Issue.6 , pp. 247-251
    • Beneš, J.1    Sýkorová, B.2
  • 12
    • 77952155563 scopus 로고    scopus 로고
    • Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection
    • Howell MD, Novack V, Grugurich P, et al. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med 2010;170(9):784-790.
    • (2010) Arch Intern Med , vol.170 , Issue.9 , pp. 784-790
    • Howell, M.D.1    Novack, V.2    Grugurich, P.3
  • 13
    • 33845304266 scopus 로고    scopus 로고
    • Update on Clostridium difficile associated disease
    • Cloud J, Kelly CP. Update on Clostridium difficile associated disease. Current Opinion in Gastroenterology. 2007;23(1):4-7.
    • (2007) Current Opinion in Gastroenterology , vol.23 , Issue.1 , pp. 4-7
    • Cloud, J.1    Kelly, C.P.2
  • 14
    • 55249120179 scopus 로고    scopus 로고
    • New advances in Clostridium difficile infection: Changing epidemiology, diagnosis, treatment and control
    • DuPont HL, Garey K, Caeiro JP, Jiang ZD. New advances in Clostridium difficile infection: changing epidemiology, diagnosis, treatment and control. Curr Opin Infect Dis. 2008;21:500-507.
    • (2008) Curr Opin Infect Dis , vol.21 , pp. 500-507
    • DuPont, H.L.1    Garey, K.2    Caeiro, J.P.3    Jiang, Z.D.4
  • 16
    • 70649107673 scopus 로고    scopus 로고
    • European Society of Clinical Microbiology and Infectious Diseases (ESCMID): Treatment guidance document for Clostridium difficile infection (CDI)
    • Bauer MP, Kuijper EJ, Dissel JT. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect. 2009;15:1067-1079.
    • (2009) Clin Microbiol Infect , vol.15 , pp. 1067-1079
    • Bauer, M.P.1    Kuijper, E.J.2    Dissel, J.T.3
  • 17
    • 36549073638 scopus 로고    scopus 로고
    • Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027
    • DOI 10.1111/j.1572-0241.2007.01539.x
    • Pépin J, Valiquette L, Gagnon S, Routhier S, Brazeau I. Outcomes of Clostridium dificile - associated disease treated with metroniazole or vancomycin before and after the emergence of NAPI/027. AM J Gastroenterol. 2007;102:2781-2788. (Pubitemid 350179349)
    • (2007) American Journal of Gastroenterology , vol.102 , Issue.12 , pp. 2781-2788
    • Pepin, J.1    Valiquette, L.2    Gagnon, S.3    Routhier, S.4    Brazeau, I.5
  • 18
    • 36048950259 scopus 로고    scopus 로고
    • Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system
    • DOI 10.1016/j.jinf.2007.09.015, PII S0163445307007840
    • Belmares J, Gerding DN, Prada JP, et al. Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system. Journal of Infection. 2007;55:495-501. (Pubitemid 350082477)
    • (2007) Journal of Infection , vol.55 , Issue.6 , pp. 495-501
    • Belmares, J.1    Gerding, D.N.2    Parada, J.P.3    Miskevics, S.4    Weaver, F.5    Johnson, S.6
  • 20
    • 34547133720 scopus 로고    scopus 로고
    • A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity
    • DOI 10.1086/519265
    • Zar FA, Bakkanagari SR, Moorthi KMLST, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. CID. 2007;45:302-307. (Pubitemid 47101025)
    • (2007) Clinical Infectious Diseases , vol.45 , Issue.3 , pp. 302-307
    • Zar, F.A.1    Bakkanagari, S.R.2    Moorthi, K.M.L.S.T.3    Davis, M.B.4
  • 21
    • 36549016574 scopus 로고    scopus 로고
    • The changing face of Clostridium difficile: What treatment options remain?
    • DOI 10.1111/j.1572-0241.2007.01533.x
    • Shen EP, Surawicz CM. The Changing Face of Clostridium difficile: What treatment options remain? Am J Gastroenterol. 2007;102:2789-2792. (Pubitemid 350179346)
    • (2007) American Journal of Gastroenterology , vol.102 , Issue.12 , pp. 2789-2792
    • Shen, E.P.1    Christina, M.S.2
  • 23
    • 77950861655 scopus 로고    scopus 로고
    • Success of self-administered home fecal transplantation for chronic Clostridium difficile infection
    • Silverman MS, Davis I, Pillai DR. Success of self-administered home fecal transplantation for chronic Clostridium difficile infection. Clinical Gastroenterology and Hematology. 2010;8: 471-473.
    • (2010) Clinical Gastroenterology and Hematology , vol.8 , pp. 471-473
    • Silverman, M.S.1    Davis, I.2    Pillai, D.R.3
  • 24
    • 77950936854 scopus 로고    scopus 로고
    • Clinical predictors and risk factors for relapsing Clostridium difficile infection
    • Cadena J, Thompson GR, Patterson JE, et al. Clinical predictors and risk factors for relapsing Clostridium difficile infection. Am J Med Sci. 2010; 339(4): 350-355.
    • (2010) Am J Med Sci , vol.339 , Issue.4 , pp. 350-355
    • Cadena, J.1    Thompson, G.R.2    Patterson, J.E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.